Excess adiposity, particularly visceral fat, is associated with reduced GLP-1 secretion and impaired incretin effect
For researchers investigating growth factor biology, muscle physiology, or localized peptide delivery strategies, IGF-1 DES provides valuable insights into structure-activity relationships and the importance of IGFBP regulation in normal IGF-1 physiology
Composition GHK-Cu: 100 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Peptide identity and purity assessment Assay development and calibration for quantitative analysis Chromatographic method optimization for impurity profiling Stability characterization of a lyophilized peptide under laboratory storage conditions Documentation Lot-specific COA available Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
10.1021/op900059x 56 CohenG.SinetP
Supporting your natural GLP-1 system through food and lifestyle is often the gentlest, most sustainable first step and one that can help you thrive for decades to come
Bottom Line BPC157 remains an experimental peptide with mechanistic plausibility derived from preclinical models but insufficient human data to claim clinical efficacy or long term safety, and its regulatory and anti doping status increase risk for patients and athletes considering unsupervised use
